ALEMBIC PHARMACEUTICALS LTD. - 533573 - Alembic Pharmaceuticals Limited Received An Establishment Inspection Report (EIR) For Its Oral Solid Formulation Facility(F-1) At Panelav

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Slowing Down Stock

801.1000 4.20 (0.53%)

NSE Jan 13, 2026 15:31 PM

27.69% Fall from 52W High

Volume: 36,931

Alembic Pharmaceuticals Ltd.

27 Sep 2024

801.10

0.53%

Company Update

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Alembic Pharmaceuticals Limited Received An Establishment Inspection Report (EIR) For …

BSE India

We are pleased to inform the exchanges that the Company has received an Establishment Inspection Report for its Oral Solid Formulation Facility (F-1) at Panelav from USFDA.

More from Alembic Pharmaceuticals Ltd.

Recommended

Market closes lower, dragged down by foreign investor outflows and mixed earnings

Trendlyne Marketwatch | 13 Jan 2026, 04:07PM

IPO wave continues as Amagi Media and Five SMEs open for subscription

| 12 Jan 2026, 06:40PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals